Skip to main content

Table 5 Overview of recent studies on intrauterine hCG infusion

From: Intrauterine administration of human chorionic gonadotropin does not improve pregnancy and life birth rates independently of blastocyst quality: a randomised prospective study

Study

No. of ETs and patients

Maternal Age (Mean)

Type and Day of ET

hCG infusion/ hCG source

IR

cPR

LBR

Mansour et al., 2011 [19]

212 ETs in first IVF/ICSI cycle (male factor)

Control: 28.3a hCG: 28.4a

Fresh Day 2 or 3

500 IU purified urinary hCG (IBSA) 7 min prior ET

Control: 29.5 % hCG: 41.6 %

Control: 60 % hCG: 75 %

 

Rebolloso et al., 2013 [22]

121 ETs IVF/ICSI cycles (38 in hCG group)

n.d.

n.d. Day 3 (n = 79) Day 5 (n = 42)

500 IU urinary hCG (n.d.) 7 min before ET

Control: 17.5 % hCG: 17.7 %

Control: 26.3 % hCG: 26.5 %

 

Zarei et al., 2014 [20]

182 ETs in first IVF/ICSI cycle

Control: 31.3a hCG: 29.9a

Fresh Day 3

250 μg rhCG (Ovitrelle) (equivalent to 6,500 IU) 12 min prior ET

Control: 22.4 % hCG: 36.9 %

Control 18.4 % hCG: 32.1 %

 

Santibañez et al., 2014 [21]

210 IVF and ICSI cycles including donor and autologous ETs

Control: 37.3a hCG: 36.4a

Fresh and frozen Day 3

500 IU purified urinary hCG (Choragon) 4 min prior ET

 

Control: 33.0 % hCG: 50.4 %

 

Riboldi et al., 2013 [12]

99 ETs in women >35a, > 2 IVF attempts

Control: 39.2a hCG: 39.2a

Frozen Blastocysts Day (n.d.)

500 IU rhCG (n.d.) 6 hours prior ET

 

Control: 36.1 % hCG 39.3 %

 

Hong et al., 2014 [27]

300 ETs with or without PGS

Control: 35.1a hCG: 35.0a

Fresh and frozen Day 6

500 IU urinary hCG (Novarel) 3 min prior ET

Control: 48.1 % hCG: 44.2 %

Control: 58.8 % hCG: 52.0 %

 

Our results

182 ETs in women ≤43a without RIF

Control: 35.5a hCG: 36.1a All: 35.8a

Fresh Day 5

500 IU urinary hCG (Pregnyl) 2 days prior ET

Top Blastocysts Control: 42.1 % hCG: 40.0 % Non-top Blastocysts Control 15.6 % hCG 15.9 %

Top Blastocysts Control: 57.1 % hCG: 52.1 % Non-top Blastocysts Control: 20.5 % hCG: 19.5 %

Top Blastocysts Control: 53.1 % hCG: 50.0 % Non-top Blastocysts Control: 18.2 % hCG: 17.1 %

Our results

1004 ETs in women ≤43a without RIF

Control: 36.7a hCG: 37.1a All: 36.9a

Fresh Day 5

500 IU urinary hCG (Pregnyl) 3 min prior ET

Top Blastocysts Control: 42.4 % hCG: 44.9 % Non-top Blastocysts Control: 27.1 % hCG: 21.9 %

Top Blastocysts Control: 54.8 % hCG: 59.2 % Non-top Blastocysts Control: 40.8 % hCG: 33.1 %

Top Blastocysts Control: 48.4 % hCG 53.3 % Non-top Blastocysts Control: 35.0 % hCG: 28.7 %

  1. a: years; cPR: clinical pregnancy rate; IR: implantation rate; LBR: live birth rate; n.d.: not defined; RIF: recurrent implantation failure
  2. Summary of different studies analyzing the putative benefit of intrauterine hCG supplementation in correlation to the IVF outcome (IR, cPR and LBR)